Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1741180 Target Snapshot

Mitochondrial import inner membrane translocase subunit TIM23 · SINGLE PROTEIN · Saccharomyces cerevisiae S288c

753Compounds
3Assays
2Approved Drugs
779.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P32897. Use UniProt P32897 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P32897 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Mitochondrial import inner membrane translocase subunit TIM23 as ChEMBL target CHEMBL1741180, mapped to UniProt P32897. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Mitochondrial import inner membrane translocase subunit TIM23
SINGLE PROTEIN · Saccharomyces cerevisiae S288c
As of 2026-09-14
ChEMBL target ID
CHEMBL1741180
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P32897
Mitochondrial import inner membrane translocase subunit TIM23
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Mitochondrial import inner membrane translocase subunit TIM23 is the right protein anchor across sources, using UniProt P32897 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMitochondrial import inner membrane translocase subunit TIM23
UniProt AccessionP32897
Component TypeProtein
Sequence Length222 aa

Mitochondrial import inner membrane translocase subunit TIM23

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Mitochondrial import inner membrane translocase subunit TIM23, mapped to UniProt P32897. Sequence length is 222 aa.

Mapped IDP32897
Review nameMitochondrial import inner membrane translocase subunit TIM23
OrganismSaccharomyces cerevisiae S288c
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
1
Phase I
Assay Mix

Activity Type Distribution

IC50779.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3199050 6.57 IC50 270.0 Preclinical
CHEMBL1421736 6.42 IC50 380.0 Preclinical
CHEMBL1449627 6.41 IC50 390.0 Preclinical
CHEMBL1309497 6.34 IC50 459.0 Preclinical
CHEMBL1519298 6.32 IC50 480.0 Preclinical
CHEMBL2003655 6.24 IC50 570.0 Preclinical
CHEMBL1992176 6.21 IC50 617.0 Preclinical
CHEMBL1985130 6.1 IC50 787.0 Preclinical
CHEMBL51085 6.06 IC50 880.0 Clinical
CHEMBL1323644 6.05 IC50 897.0 Preclinical
Distribution

pChEMBL Value Distribution

266
5.0
47
5.5
11
6.0
1
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

3
Total Assays
705
Tested Compounds
1
Assay Types
Functional — 3 assays, 705 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 705 5.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine